EVATHERA Trademark

Trademark Overview

On Tuesday, May 18, 2021, a trademark application was filed for EVATHERA with the United States Patent and Trademark Office. The USPTO has given the EVATHERA trademark a serial number of 90718151. The federal status of this trademark filing is REPORT COMPLETED SUSPENSION CHECK - CASE STILL SUSPENDED as of Tuesday, October 8, 2024. This trademark is owned by Molecular Targeting Technologies, Inc.. The EVATHERA trademark is filed in the Pharmaceutical Products category with the following description:

Diagnostic radiopharmaceutical preparations
evathera

General Information

Serial Number90718151
Word MarkEVATHERA
Filing DateTuesday, May 18, 2021
Status654 - REPORT COMPLETED SUSPENSION CHECK - CASE STILL SUSPENDED
Status DateTuesday, October 8, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesDiagnostic radiopharmaceutical preparations

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, August 16, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameMolecular Targeting Technologies, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWest Chester, PA 19380

Trademark Events

Event DateEvent Description
Monday, August 16, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, July 19, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, May 21, 2021NEW APPLICATION ENTERED
Thursday, January 27, 2022ASSIGNED TO EXAMINER
Friday, February 4, 2022NON-FINAL ACTION E-MAILED
Friday, February 4, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, February 4, 2022NON-FINAL ACTION WRITTEN
Tuesday, July 19, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, August 12, 2022ASSIGNED TO LIE
Monday, August 15, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, August 15, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, September 30, 2022LETTER OF SUSPENSION E-MAILED
Tuesday, August 16, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, August 16, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, September 30, 2022EXAMINERS AMENDMENT -WRITTEN
Friday, September 30, 2022EXAMINERS AMENDMENT E-MAILED
Friday, September 30, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, September 30, 2022EXAMINER'S AMENDMENT ENTERED
Friday, September 30, 2022SUSPENSION LETTER WRITTEN
Friday, September 30, 2022NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, October 8, 2024REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Thursday, April 10, 2025SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Thursday, March 30, 2023REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Thursday, September 28, 2023REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Friday, March 29, 2024REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED

Related Keywords

evathera preparations radiopharmaceutical diagnostic